BCL9L was the only gene for which all mutations found were clearly inactivating, with one nonsense mutation Q713∗ in tumor 379, one nonsense mutation R716∗ in the cell line SW1463, and one splice-site variant (exon 5 + 1 G > A) in the tumor sample 363. The gene discussed is BCL9L; the disease is neoplasm.